Vegan, Clean & Cruelty-Free — Three Confused Labels and a K-Beauty Export Strategy
Vegan (no animal-derived ingredients), cruelty-free (no animal testing), and clean (free-from, with no legal definition) are different promises. The vegan cosmetics market is set to reach $11.1 billion by 2031 at ~14% a year, but missing certifications and per-market rules invites a greenwashing backlash. Here is how to separate the three and use them as export strategy.
Read more →
The K-Beauty Success Formula Built on Korean OEM/ODM — How Indie Brands Go Global
Behind K-beauty indie success is the ecosystem of Cosmax and Kolmar Korea, the world's two largest ODMs. Capital-light startups ‘rent’ proven formulas to launch, then ride a single hero SKU and digital validation all the way to global retail. Here are the recurring success patterns — and their limits.
Read more →
Reading Olive Young Rankings as Product-Planning Signals
Olive Young rankings are not a popularity chart but compressed data on the formats, ingredients, prices, sizes, and claims the market responded to. Planners should read recurring patterns and exceptions — correcting for promotions, season, and private-brand effects — and translate them into an OEM/ODM brief.
Read more →
2026 K-Beauty Export & Regulation Signals — What Buyers Should Know
In 2025, Korea's cosmetics exports hit a record $11.4 billion and reached #2 in the world, and the largest export country shifted from China to the US. Meanwhile a 15% US tariff, mandatory MoCRA GMP, and tighter EU rules raised the cost of entry. Here are the market-by-market signals export brands should know now.
Read more →Cosmetics OEM vs ODM vs OBM: Choosing by What You'll Own
OEM means the brand leads concept and formula while the factory manufactures; ODM means the manufacturer proposes the formula and development; OBM means the brand owns the product, trademark, IP, and distribution. Indie K-beauty brands typically validate with ODM, then move formula IP and exclusivity to the brand as they scale.
Read more →
Exosomes & Microbiome in Cosmetics: Evidence Grades and Claim Boundaries (2025)
Exosomes and the microbiome are two pillars of next-gen K-beauty, but their regulatory weight moved in opposite directions. Korea expanded ‘exosome’ to a prohibited cosmetic ad expression in 2025 and bans human-derived cells and tissues as ingredients, while the microbiome is settling into a postbiotic-led barrier-and-soothing concept.
Read more →Cosmetics Export Compliance: MoCRA, CPNP & ANVISA in Practice
Treating K-beauty export as 'build first, register later' is risky. The US runs on MoCRA facility and product listing, the EU on CPNP notification with a Responsible Person, and Brazil on ANVISA notification or registration — so ingredients, labeling, and safety data must be aligned from the product-planning stage.
Read more →PDRN in Cosmetics: Efficacy Evidence vs. Claim Boundaries
PDRN draws attention from tissue-repair research and injectable/medical-device use, but topical cosmetics cannot make medical claims like wound healing, regeneration, or anti-inflammatory treatment. Brands should work within cosmetic claim ranges — hydration, firmness, skin texture, soothing support — while aligning ingredient stability, labeling evidence, and export rules.
Read more →
Surviving the Tariff Era: A K-Beauty Export Strategy Beyond America (2026)
Korea's cosmetics exports hit a record in 2026 — yet a 15% US tariff, the end of de minimis, and MoCRA now squeeze indie brands head-on. Here are four strategies, designed in from the factory floor: diversify beyond the US (Gulf, Latin America, India), compete on efficacy not price, build a brand rather than a product, and turn regulation into a moat.
Read more →5 K-Beauty Ingredient Trends to Watch in 2026
In 2026, K-beauty centers on barrier repair (ceramides, panthenol), microbiome ferments, low-irritation exosomes, PDRN salmon-DNA, and upcycled naturals. Here are the five ingredient directions global buyers ask for most.
Read more →How Buyers Read the Olive Young Skincare Ranking
Olive Young's weekly ranking is a live demand signal from Korean consumers. Reading entry patterns, price bands, sizes and claims by category tells you what to build.
Read more →A Starter Guide to Korean OEM/ODM for Overseas Brands
The five things every overseas brand hits first when manufacturing in Korea — factory contact, MOQ, sample lead time, regulation and IP — explained step by step, from OEM vs ODM to getting a quote.
Read more →